Newamsterdam Pharma Company N.v. · NASDAQ:NAMS
Newamsterdam Pharma Company N.v. shareholders
Newamsterdam Pharma Company N.v. on 6ix: holders from US fund reports; insider trades reported in the US. Largest: SMALLCAP World Fund Inc, Strategic Advisers Fidelity U.S. Total Stock Fund and Fidelity Contrafund. Each with its filing.
| Holder | Shares | % of Newamsterdam Pharma Company N.v. | Change | As of |
|---|---|---|---|---|
| SMALLCAP World Fund Inc | 9.27M | +870K | Jun 30, 2026 | |
| Strategic Advisers Fidelity U.S. Total Stock Fund | 2.01M | +552K | May 31, 2026 | |
| Fidelity Contrafund | 1.68M | +415K | Jun 30, 2026 | |
| New Economy Fund | 957K | no change | May 31, 2026 | |
| T. Rowe Price Health Sciences Fund, Inc. | 913K | new | Jun 30, 2026 | |
| Select Health Care Portfolio | 690K | +20,000 | May 31, 2026 | |
| Capital Group U.S. Small and Mid Cap ETF | 609K | +404K | May 31, 2026 | |
| iShares Biotechnology ETF | 566K | +28,356 | Jun 30, 2026 | |
| PGIM Jennison Health Sciences Fund | 534K | no change | May 29, 2026 | |
| Small Cap Growth Fund | 524K | +91,985 | Jul 31, 2026 |